Freestone Grove Partners’s Innoviva INVA Stock Holding History

Freestone Grove Partners’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Buy	118,877 +37,031	+45%	+$848K	0.02%	392
2026 Q1	$1.91M	Sell	81,846 -9,827	-11%	-$212K	0.01%	377
2025 Q4	$1.83M	Sell	91,673 -84,748	-48%	-$1.65M	0.01%	406
2025 Q3	$3.22M	Buy	176,421 +155,598	+747%	+$3.03M	0.02%	351
2025 Q2	$418K	Buy	20,823 +948	+5%	+$18.2K	﹤0.01%	550
2025 Q1	$360K	Sell	19,875 -18,950	-49%	-$340K	﹤0.01%	448
2024 Q4	$674K	Buy	+38,825	New	+$746K	0.01%	336

Other funds holding INVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Freestone Grove Partners's INVA Position: Q2 2026 in Review

Freestone Grove Partners increased its Innoviva (INVA) stake by 45% in Q2 2026, buying an estimated $848K and bringing the position to 118,877 shares worth $2.7M. The position accounts for 0.02% of the portfolio, ranked #392.

Freestone Grove Partners first reported a position in INVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.22M in Q3 2025. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

Freestone Grove Partners held 118,877 shares of Innoviva worth $2.7M as of Q2 2026.
Freestone Grove Partners bought 37,031 Innoviva shares in Q2 2026, an estimated $848K.
Innoviva made up 0.02% of Freestone Grove Partners's portfolio in Q2 2026, its #392 holding.
Freestone Grove Partners first reported a position in Innoviva in Q4 2024 and has held it in 7 quarters since.
Freestone Grove Partners's Innoviva position peaked at $3.22M in Q3 2025.
309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.